Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Radiol Oncol. 2011 Dec;45(4):259-66. doi: 10.2478/v10019-011-0034-3. Epub 2011 Oct 8.
Cathepsin H is a cysteine protease considered to play a major role in tumor progression, however, its precise function in tumorigenesis is unclear. Cathepsin H was recently proposed to be involved in processing of bone morphogenetic protein 4 (BMP-4) in mice. In order to clarify whether cathepsin H also regulates BMP-4 in humans, its impact on BMP-4 expression, processing and degradation was investigated in prostate cancer (PC-3), osteosarcoma (HOS) and pro-monocytic (U937) human cell lines.
BMP-4 expression was founded to be regulated by cathepsin H using PCR array technology and confirmed by real time PCR. Immunoassays including Western blot and confocal microscopy were used to evaluate the influence of cathepsin H on BMP-4 processing.
In contrast to HOS, the expression of BMP-4 mRNA in U937 and PC3 cells was significantly decreased by cathepsin H. The different regulation of BMP-4 synthesis could be associated with the absence of the mature 28 kDa cathepsin H form in HOS cells, where only the intermediate 30 kDa form was observed. No co-localization of BMP-4 and cathepsin H was observed in human cell lines and the multistep processing of BMP-4 was not altered in the presence of specific cathepsin H inhibitor. Isolated cathepsin H does not cleave mature recombinant BMP-4, neither with its amino- nor its endopeptidase activity.
Our results exclude direct proteolytic processing of BMP-4 by cathepsin H, however, they provide support for its involvement in the regulation of BMP-4 expression.
组织蛋白酶 H 是一种半胱氨酸蛋白酶,被认为在肿瘤进展中起主要作用,但其在肿瘤发生中的确切功能尚不清楚。组织蛋白酶 H 最近被提出参与了小鼠骨形态发生蛋白 4(BMP-4)的加工。为了阐明组织蛋白酶 H 是否也调节人类的 BMP-4,在前列腺癌(PC-3)、骨肉瘤(HOS)和原单核细胞(U937)人细胞系中研究了其对 BMP-4 表达、加工和降解的影响。
使用 PCR 阵列技术发现 BMP-4 表达受组织蛋白酶 H 调节,并通过实时 PCR 证实。免疫测定法,包括 Western blot 和共聚焦显微镜,用于评估组织蛋白酶 H 对 BMP-4 加工的影响。
与 HOS 相反,BMP-4 mRNA 在 U937 和 PC3 细胞中的表达明显减少。BMP-4 合成的不同调节可能与 HOS 细胞中缺乏成熟的 28 kDa 组织蛋白酶 H 形式有关,其中仅观察到中间 30 kDa 形式。在人细胞系中未观察到 BMP-4 和组织蛋白酶 H 的共定位,并且在存在特异性组织蛋白酶 H 抑制剂的情况下,BMP-4 的多步加工未改变。分离的组织蛋白酶 H 不能切割成熟的重组 BMP-4,无论是其氨基肽酶活性还是内肽酶活性。
我们的结果排除了组织蛋白酶 H 对 BMP-4 的直接蛋白水解加工,但它们支持其参与 BMP-4 表达的调节。